Quarterly Result
| Astrazeneca Pharma India Ltd Industry: (Pharmaceuticals - Multinational) |
|---|
|
BSE Code:
506820
ISIN Demat:
INE203A01020
Book Value(₹): 349.12 NSE Symbol:
ASTRAZEN
Div & Yield(%):
0.57
Market Cap(₹ Cr): 15,912.80 P/E(TTM):
91.73
EPS(TTM):
69.39
Face Value(₹): 2.00 |
| Particulars | Jun 2026 (₹ Cr) | Mar 2026 (₹ Cr) | Dec 2025 (₹ Cr) |
|---|---|---|---|
| Gross Sales | 682.79 | 578.61 | 611.57 |
| Excise Duty | 0.00 | 0.00 | 0.00 |
| Net Sales | 682.79 | 578.61 | 611.57 |
| Other Operating Income | 0.00 | 0.00 | 0.00 |
| Other Income | 9.23 | 5.95 | 6.61 |
| Total Income | 692.02 | 584.56 | 618.18 |
| Total Expenditure | 634.09 | 518.78 | 566.74 |
| PBIDT | 57.93 | 65.78 | 51.44 |
| Interest | 1.95 | 2.04 | 1.06 |
| PBDT | 55.98 | 63.74 | 50.38 |
| Depreciation | 5.23 | 5.60 | 3.84 |
| Tax | 10.87 | 14.31 | 4.00 |
| Fringe Benefit Tax | 0.00 | 0.00 | 0.00 |
| Deferred Tax | 1.95 | -1.05 | 9.95 |
| Reported Profit After Tax | 37.93 | 44.88 | 32.59 |
| Extra-ordinary Items | -0.18 | -0.81 | 1.04 |
| Adjusted Profit After Extra-ordinary item | 38.11 | 45.69 | 31.55 |
| EPS (Unit Curr.) | 15.17 | 17.95 | 13.04 |
| EPS (Adj) (Unit Curr.) | 15.17 | 17.95 | 13.04 |
| Calculated EPS (Unit Curr.) | 15.17 | 17.95 | 13.04 |
| Calculated EPS (Adj) (Unit Curr.) | 15.17 | 17.95 | 13.04 |
| Calculated EPS (Ann.) (Unit Curr.) | 60.69 | 71.81 | 52.14 |
| Calculated EPS (Adj) (Ann.) (Unit Curr.) | 60.69 | 71.81 | 52.14 |
| Book Value (Unit Curr.) | 0.00 | 0.00 | 0.00 |
| Dividend (%) | 0.00 | 0.00 | 0.00 |
| Equity | 5.00 | 5.00 | 5.00 |
| Reserve & Surplus | 0.00 | 0.00 | 0.00 |
| Face Value | 2.00 | 2.00 | 2.00 |
| Public Shareholding (No. Of Shares) | 0.00 | 0.00 | 0.00 |
| Public Shareholding (% in Equity) | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - No. of Shares | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - % in Total Promoters Holding | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - % in Total Equity | 0.00 | 0.00 | 0.00 |
| Non Encumbered - No. of Shares | 0.00 | 0.00 | 0.00 |
| Non Encumbered - % in Total Promoters Holding | 0.00 | 0.00 | 0.00 |
| Non Encumbered - % in Total Equity | 0.00 | 0.00 | 0.00 |
| PBIDTM(%) | 8.48 | 11.37 | 8.41 |
| PBDTM(%) | 8.20 | 11.02 | 8.24 |
| PATM(%) | 5.56 | 7.76 | 5.33 |